Big Law

CV Sciences, Inc. Misled Shareholders According to a Recently Filed Lawsuit

A purchaser of CV Sciences, Inc has filed a shareholder derivative complaint against the company’s officers and directors for alleged breaches of fiduciary duties from June 19, 2017 through the present. CV Sciences is a life science company that focuses on developing products using synthetic cannabidiol (“CBD”).

Read the source article at businesswire.com

    Leave a Review or Comment

    Your email address will not be published. Required fields are marked *

    Back to top button